国家银屑病基金会COVID-19工作组:疫情期间银屑病管理指南(第一版)
国家银屑病基金会组建18名投票成员的专家组,采用德尔菲法制定疫情期间银屑病管理指南。工作组批准22条推荐声明,其中9条高共识、13条中等共识,涵盖疾病及治疗对COVID-19风险的影响、医疗优化、感染预防及感染后处理。指南为动态文件,将随数据更新。
要点
- 22条推荐声明均获推荐,9条高共识、13条中等共识。
- 声明涵盖银屑病及治疗对COVID-19风险与结局的影响。
- 指导疫情期间医疗优化、感染预防和感染后处理。
核心结论
- 工作组批准的22条声明为疫情期间银屑病患者管理提供指导。
研究设计与样本
- 工作组由18名投票成员组成,专业涵盖皮肤科、风湿科、流行病学、感染病和重症监护,另有非投票成员。
- 通过德尔菲流程制定指南,临床问题来源于国家银屑病基金会收到的提问。
主要发现
- 所有声明的平均投票处于同意类别。
- 22条声明均被推荐,其中9条高共识、13条中等共识。
关键数值与推荐
- 22条推荐声明涉及疾病及治疗对COVID-19风险与结局的影响、疫情期间医疗优化、降低SARS-CoV-2感染风险的措施及感染COVID-19后的处理。
临床怎么用
- 临床可参照22条声明管理疫情期间的银屑病患者。
- 指南为动态文件,将随新数据更新。
局限性
- 许多指南声明背后的证据质量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. STUDY DESIGN: A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care was convened. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation (NPF) staff. Clinical questions relevant to the psoriatic disease community were informed by questions received by the NPF. A Delphi process was conducted. RESULTS: The TF approved 22 guidance statements. The average of the votes was within the category of agreement for all statements. All guidance statements proposed were recommended, 9 with high consensus and 13 with moderate consensus. LIMITATIONS: The evidence behind many guidance statements is limited in quality. CONCLUSION: These statements provide guidance for the management of patients with psoriatic disease on topics ranging from how the disease and its treatments impact COVID-19 risk and outcome, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 and what they should do if they develop COVID-19. The guidance is intended to be a living document that will be updated by the TF as data emerge.
引用
- Gelfand JM, Armstrong AW, Bell S, et al. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1. J Am Acad Dermatol. 2020. PMID: 32891785. doi:10.1016/j.jaad.2020.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。